| 000 | 01844 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517113019.0 | ||
| 264 | 0 | _c20170407 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1559-131X | ||
| 024 | 7 |
_a10.1007/s12032-016-0824-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRodríguez Garzotto, Analia | |
| 245 | 0 | 0 |
_aBlood-based biomarkers for monitoring antiangiogenic therapy in non-small cell lung cancer. _h[electronic resource] |
| 260 |
_bMedical oncology (Northwood, London, England) _cOct 2016 |
||
| 300 |
_a105 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBevacizumab _xadministration & dosage |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xblood |
| 650 | 0 | 4 |
_aCell Adhesion Molecules _xblood |
| 650 | 0 | 4 |
_aE-Selectin _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _xmetabolism |
| 650 | 0 | 4 |
_aLung Neoplasms _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xblood |
| 650 | 0 | 4 | _aTranscriptome |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xblood |
| 700 | 1 | _aDíaz-García, C Vanesa | |
| 700 | 1 | _aAgudo-López, Alba | |
| 700 | 1 | _aPrieto García, Elena | |
| 700 | 1 | _aPonce, Santiago | |
| 700 | 1 | _aLópez-Martín, José A | |
| 700 | 1 | _aPaz-Ares, Luis | |
| 700 | 1 | _aIglesias, Lara | |
| 700 | 1 | _aAgulló-Ortuño, M Teresa | |
| 773 | 0 |
_tMedical oncology (Northwood, London, England) _gvol. 33 _gno. 10 _gp. 105 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12032-016-0824-y _zAvailable from publisher's website |
| 999 |
_c26366942 _d26366942 |
||